Become A Featured Company

Liberty Health Sciences Announces Strategic Partnership with Seed Junky™ Genetics to Bring Unique Cannabis Strains to Florida

Ryan Allway

August 17th, 2020

News, Top News

TORONTO, Aug. 17, 2020 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high-quality cannabis, announced today a partnership with Seed Junky™ Genetics (SJG) www.seedjunky.com, a seasoned California-based pioneer in the cannabis industry, to sell and distribute its world-renowned and potent assortment of award-winning cannabis strains. SJG has developed an unparalleled amount of varieties of genetics and is a leader in cannabis cultivation, excelling in the smokable flower category. Liberty plans to roll out a variety of SJG products to all of its Florida locations between November and December of this year.

Dedicated to trailblazing innovation and driven by experienced scientists using state-of-the-art technology, SJG follows strict breeding standards, improving standard product lines and ensuring customers receive only the finest quality genetics. Top California cannabis brands credit SJG for being able to offer world-class and powerful cultivars to the marketplace. SJG’s THC content has been known to exceed 30 percent and is known for its record-breaking yielding in gamma of strains.

SJG has made a lasting name for itself by creating notable strains including Wedding Cake, Ice Cream Cake, The Soap, Christmas Tree, Georgia Pie, Kush Mints, LA Kush Cake, Jealousy, Emerald Cut, Emergen-C, Jungle Cake, Animal Mints, and countless other strains.

“This is a historical moment for Liberty and the entire state of Florida as we embark on this groundbreaking partnership with Seed Junky™ Genetics,” said Victor Mancebo, Chief Executive Officer of Liberty. “We are excited to introduce our patients to a true premium connoisseur cannabis product. While many cannabis companies are still working with 30-year-old strains, SJG is constantly developing and maintaining new genetics that have become exceptionally unique to cannabis markets in existence today. This also comes at a time when we have just completed our build-out of our new state-of-the-art tissue culture lab, where we will develop, mitigate, control, correct, and store genetics for the company as we expand and develop the Florida market, subject to approval from the Florida Department of Health.”

Seed Junky™ Genetics was created by Jbeezy, a distinguish breeder with more than 15 years of breeding experience in combining high THC and high terpene blends. Jbeezy has demonstrated the ability to identify flavors and selections that connoisseurs of cannabis around the world love. What remains constant with the top brands in the industry is Seed Junky™ Genetics.

Unlike other breeders, the Seed Junky™ team cultivates in large-scale production facilities that allows their team to provide standard operating procedures to their cultivation partners. This allows the cultivator to hit the ground running and optimize the cultivation of each cultivar. Seed Junky™ Genetics understands that providing commercially viable genetics to the growers ensures that the end user will receive the highest quality end product. Jbeezy is a relentless innovator who prides himself on bringing “the new, new” to the cannabis industry.

Patients may place an order online at www.libertyhealthsciences.com for in-store pick-up or delivery.

About Seed Junky™ Genetics

Seed Junky™ Genetics is a seasoned California-based pioneer in the Cannabis industry, with 15 years of breeding experience. Seed Junky™ prides itself on identifying flavors and selections that connoisseurs of cannabis around the world love, as well as cultivating in large scale production facilities. For more information visit: www.seedjunky.com

About Liberty Health Sciences Inc.

Liberty is the cannabis provider committed to providing a trusted, high-quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty’s measured approach to expansion opportunities is focused on maximizing returns to shareholders, while keeping consumers’ well-being at the forefront of what we do. For more information visit: www.libertyhealthsciences.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “believe”, “plan”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company’s production capabilities, expectations concerning the receipt of all necessary approvals from the Florida Department of Health, expectations concerning the opening of new dispensaries and the expansion of its greenhouse space, and the Company’s future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions, or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

SOURCE Liberty Health Sciences Inc.

For further information: Media Contacts: Dwain Schenck, (203) 223-5230, dwain@schenckstrategies.com; Victor Mancebo, Chief Executive Officer, (352) 388-3178, VMancebo@libertyhealthsciences.com

Related Links

http://www.libertyhealthsciences.com/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading